International Biotechnology Trust PLC Nkarta, Inc. Transaction History

International Biotechnology Trust PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$7.77 - $19.44 $77,964 - $195,060	-10,034 Closed	0 $0
Q1 2022 May 20, 2022	SELL	$8.66 - $14.99 $261,237 - $452,188	-30,166 Reduced 75.04%	10,034 $114,000
Q4 2021 Feb 15, 2022	SELL	$12.79 - $26.88 $207,773 - $436,665	-16,245 Reduced 28.78%	40,200 $617,000
Q3 2021 Nov 12, 2021	SELL	$26.67 - $38.76 $361,511 - $525,391	-13,555 Reduced 19.36%	56,445 $1.57 Million
Q2 2021 Aug 11, 2021	BUY	$23.94 - $36.68 $1.68 Million - $2.57 Million	70,000 New	70,000 $2.21 Million

127

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $120M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.